Editing Patient Pathways: Lymphoma (section)

= Available supportive content for cancer patients =

Croatian translation of several Patient Guides was carried out by the Association of Women with and Treated for Cancer EVERYTHING for HER based on the approval of the European Society for Medical Oncology (ESMO).

'''ESMO Patient Guide Living with Cancer'''

This Patient Guide to Living with Cancer has been produced by the European Society for Medical Oncology (ESMO) and the European Cancer Patient Coalition (ECPC) in collaboration with the International Psycho-Oncology Society (IPOS) to help you and those like you at this important time in your life. This Guide will provide you with information on coping with your new reality, life after primary treatment, preventive care and long-term follow-up. It will also help you to keep your own personal health record, i.e. plan your own health care during your life with cancer.

The guide was translated by Dea Ajduković, PhD, and the translation was reviewed by Natalija Dedić Plavetić, PhD, MD, specialist in internal oncology, and Ljiljana Vukota, psychologist, from the EVERYTHING for HER association, on behalf of the patients.

https://www.esmo.org/content/download/131276/2458900/1/ESMO-Vodic-za-Bolesnike-Zivot-s-Rakom.pdf

'''ESMO Personalised Medicine in Oncology: A Patient Guide'''

This patient guide has been initiated by the ESMO Personalised Medicine Working Group to help patients, their family members and friends better understand the factors that can influence a personalised approach to cancer prevention, diagnosis and treatment. This booklet summarises the current knowledge on the main principles of personalised medicine, illustrating its application to several cancer types. Personalised medicine represents the future of cancer treatment, and the patient’s role is crucial in making it a reality in the near future and enabling better treatment of tumours.

The Croatian translation of the Guide was made possible by the Association of Women with and Treated for Cancer EVERYTHING for HER based on the approval of the European Society for Medical Oncology (ESMO). The text of the Croatian translation was reviewed by: Prof. Ljiljana Šerman, Prof. Floriana Bulić-Jakuš and Mrs. Ljiljana Vukota.

https://www.esmo.org/content/download/385655/7486427/1/HR-Personalizirana-Medicina-u-Onkologiji-Vodic-za-Bolesnike.pdf

'''ESMO Immune-Related Side Effects and their Management: A Guide for Patients'''

This guide has been prepared to help you, your family, friends and caregivers better understand immune-related side-effects and how to manage them. It provides information about the most common toxicities associated with modern immunotherapies (known as “immune checkpoint inhibitors”), how your oncology team can manage these symptoms and some steps you can take yourself to help minimize their impact. The medical information described in this document is based on the ESMO Clinical Practice Guidelines for the management of immunotherapy toxicities, which are designed to assist clinicians in the diagnosis, treatment and follow-up of these events. All ESMO Clinical Practice Guidelines are developed and reviewed by leading experts using evidence from the latest clinical trials, scientific research and expert opinion.

The Croatian translation of the guide was reviewed by: representative of the Croatian Society for Internal Oncology: Natalija Dedić Plavetić, MD, PhD; representative of the Croatian Thoracic Society: Marko Jakopović, MD, PhD; representative of the Association of Women with and Treated for Cancer EVERYTHING for HER: Ljiljana Vukota.

'''ESMO Cancer Treatment During the COVID-19 Pandemic: A Guide for Patients'''

The guide provides information on COVID-19 disease and its symptoms, as well as measures you can take to reduce your risk of infection. In addition, the guide provides information on the impact of the COVID-19 pandemic on various aspects of cancer treatment, including possible changes to your treatment plan and medical checkups that may be needed to protect you from infection.

The Croatian translation was reviewed by: Prim. Paula Podolski, MD, PhD, President of the Croatian Senological Society, Borislav Belev, MD, PhD, medical oncologist, National representative of the Croatian Society for Internal Oncology at ESMO and Ljiljana Vukota, representative of the EVERYTHING for HER association.

http://www.svezanju.hr/lijecenje-raka-tijekom-pandemije-covid-19-esmo-vodic-za-bolesnike/

'''ESPEN practical guideline: Clinical Nutrition in cancer'''

Malnutrition is common in cancer patients and is a consequence of the presence of the tumor and medical and surgical cancer treatments.

Malnutrition negatively affects quality of life and treatment toxicity, and it is estimated that 10-20% of cancer patients die from the consequences of malnutrition, not from the tumor itself. Therefore, nutrition plays a key role in multimodal cancer treatment.

Strong evidence shows that nutritional problems should be considered from the time of cancer diagnosis, within the diagnostic and therapeutic pathway, and should be carried out in parallel with antineoplastic treatment. However, worldwide, cancer-related malnutrition remains largely unrecognized, underestimated, and undertreated in clinical practice.

These evidence-based guidelines have been developed to translate the best available evidence and expert opinion into recommendations for multidisciplinary teams responsible for identifying, preventing and treating reversible elements of malnutrition in adult cancer patients.

<span id="directory-of-associations-offering-supportive-activities-to-cancer-patients"></span>